Literature DB >> 9689359

Inhibin-A and pro-alpha C are elevated in preeclamptic pregnancy and correlate with human chorionic gonadotropin.

R F Fraser1, M E McAsey, P Coney.   

Abstract

PROBLEM: Serum concentrations of the heterodimeric glycoprotein inhibin-A (alpha-beta A) and its alpha-subunit increase during pregnancy. The placenta is the predominant source of inhibin during pregnancy, and a paracrine role in the trophoblast has been suggested. Elevated serum concentrations of inhibin alpha-subunit as well as the glycoprotein human chorionic gonadotropin (hCG) have been described in preeclamptic pregnancy. The objectives of this investigation were to compare serum concentrations of inhibin-A and inhibin pro-alpha C in preeclamptic and normotensive pregnancy, and to examine the relationship of hCG and inhibin-A in those pregnancies. METHOD OF STUDY: A case-control design using 32 patients with preeclampsia with a single fetus at 32-40 weeks of gestation and 34 gestation age-matched normotensive control subjects was used for this investigation. Solid-phase enzyme-linked immunosorbent assays were used to measure inhibin-A and inhibin pro-alpha C in sera. An immunoradiometric assay was used to measure intact hCG.
RESULTS: Inhibin-A and inhibin pro-alpha C concentrations were significantly elevated in the sera of women with preeclampsia compared with those concentrations in normotensive control subjects (P < 0.05). A relationship of inhibin-A or pro-alpha C with severity of preeclampsia was not observed. There was a significant positive correlation of serum hCG with both inhibin-A and pro-alpha C (P < 0.05).
CONCLUSIONS: Levels of inhibin-A and the subunit pro-alpha C are increased in pregnancies complicated by preeclampsia. These findings are potentially the effect of a paracrine role of inhibin-A in the development and proliferation of the trophoblast.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9689359     DOI: 10.1111/j.1600-0897.1998.tb00386.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  3 in total

1.  Maternal serum and amniotic fluid inhibin A levels in women who subsequently develop severe preeclampsia.

Authors:  Shin-Young Kim; Hyun-Mee Ryu; Jae-Hyug Yang; Moon-Young Kim; Hyun-Kyong Ahn; Joong-Sik Shin; Jun-Seek Choi; So-Yeon Park; Jin-Mi Kim; Bom-Yi Lee; Do-Jin Kim
Journal:  J Korean Med Sci       Date:  2006-06       Impact factor: 2.153

2.  Genetic association of the activin A receptor gene (ACVR2A) and pre-eclampsia.

Authors:  E Fitzpatrick; M P Johnson; T D Dyer; S Forrest; K Elliott; J Blangero; S P Brennecke; E K Moses
Journal:  Mol Hum Reprod       Date:  2009-01-06       Impact factor: 4.025

3.  Genome-wide association scan identifies a risk locus for preeclampsia on 2q14, near the inhibin, beta B gene.

Authors:  Matthew P Johnson; Shaun P Brennecke; Christine E East; Harald H H Göring; Jack W Kent; Thomas D Dyer; Joanne M Said; Linda T Roten; Ann-Charlotte Iversen; Lawrence J Abraham; Seppo Heinonen; Eero Kajantie; Juha Kere; Katja Kivinen; Anneli Pouta; Hannele Laivuori; Rigmor Austgulen; John Blangero; Eric K Moses
Journal:  PLoS One       Date:  2012-03-14       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.